TriSalus Life Sciences (TLSIW) Total Liabilities (2020 - 2026)

TriSalus Life Sciences (TLSIW) has 7 years of Total Liabilities data on file, last reported at $58.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 7.66% year-over-year to $58.2 million; the trailing twelve-month figure through Mar 2026 stood at $58.2 million (down 7.66% YoY), and the FY2025 full-year result was $69.2 million, up 38.76% from the prior year.
• Total Liabilities for Q1 2026 stood at $58.2 million, down from $69.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $69.2 million in Q4 2025 and bottomed at $12.0 million in Q2 2022.
• The 5-year median for Total Liabilities is $49.9 million (2024), against an average of $41.2 million.
• The widest annual swing landed in 2022, when Total Liabilities tumbled 46.89%; it then soared 271.65% in 2024.
• A 5-year view of Total Liabilities shows it stood at $34.3 million in 2022, then jumped by 50.54% to $51.7 million in 2023, then dropped by 3.48% to $49.9 million in 2024, then soared by 38.76% to $69.2 million in 2025, then fell by 15.93% to $58.2 million in 2026.
• The last three Total Liabilities figures came in at $58.2 million (Q1 2026), $69.2 million (Q4 2025), and $63.2 million (Q3 2025), per Business Quant data.

Peer Comparison